 Antibodies, Viral
"Antibodies, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunoglobulins produced in response to VIRAL ANTIGENS.
| Descriptor ID |
D000914
|
| MeSH Number(s) |
D12.776.124.486.485.114.254 D12.776.124.790.651.114.254 D12.776.377.715.548.114.254
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Viral".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Viral".
This graph shows the total number of publications written about "Antibodies, Viral" by people in this website by year, and whether "Antibodies, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 4 | 6 | | 1996 | 1 | 1 | 2 | | 1997 | 0 | 3 | 3 | | 1998 | 2 | 4 | 6 | | 1999 | 2 | 3 | 5 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 3 | 5 | | 2002 | 0 | 2 | 2 | | 2003 | 2 | 4 | 6 | | 2004 | 1 | 6 | 7 | | 2005 | 2 | 4 | 6 | | 2006 | 3 | 5 | 8 | | 2007 | 4 | 6 | 10 | | 2008 | 3 | 6 | 9 | | 2009 | 2 | 11 | 13 | | 2010 | 2 | 5 | 7 | | 2011 | 5 | 3 | 8 | | 2012 | 5 | 4 | 9 | | 2013 | 4 | 5 | 9 | | 2014 | 3 | 7 | 10 | | 2015 | 8 | 7 | 15 | | 2016 | 2 | 6 | 8 | | 2017 | 5 | 13 | 18 | | 2018 | 5 | 13 | 18 | | 2019 | 8 | 8 | 16 | | 2020 | 13 | 15 | 28 | | 2021 | 23 | 23 | 46 | | 2022 | 2 | 29 | 31 | | 2023 | 0 | 12 | 12 | | 2024 | 5 | 12 | 17 | | 2025 | 8 | 4 | 12 |
To return to the timeline, click here.
Below are the most recent publications written about "Antibodies, Viral" by people in Profiles.
-
Janoff EN, Shih MC, Donskey C, Belitskaya-Levy I, Brau N, Rodriguez-Barradas MC, Chan E, Zimmerman P, Miller EK, Vaughan LB, Daniel Markley J, Goldberg AM, Sriram P, Anzueto A, Uyeda L, Zehm L, Wills A, Hutchinson C, Jones L, Peterson D, Ringer RJ, Dumont L, Gleason T, Bonomo RA, Curtis JL, Brown ST. Impact of High-Titer Convalescent Plasma on Clinical and Virologic Outcomes Among Veterans Hospitalized With SARS-CoV-2 Infection: VA CoronavirUs Research and Efficacy Studies-1 (VA CURES-1). J Med Virol. 2025 May; 97(5):e70349.
-
Godin A, Brickley EB, Connor RI, Wieland-Alter WF, Ackerman ME, Weiner JA, Modlin J, Arita M, Bandyopadhyay AS, Gast C, S?ez-Llorens X, R?ttimann RW, Van Damme P, De Coster I, Wright PF. Intestinal mucosal immune responses induced by novel oral poliovirus vaccine type 2 and Sabin monovalent oral poliovirus vaccine type 2: an analysis of data from four clinical trials. Lancet Microbe. 2025 Jun; 6(6):101028.
-
Fullerton HJ, Hills NK, Wintermark M, Dlamini N, Fox CK, Cummings DD, Bernard TJ, Beslow LA, Sun LR, Grose C, Norris PJ, Di Germanio C. Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment. Stroke. 2025 May; 56(5):1200-1209.
-
Stumpf MM, Brunetti T, Davenport BJ, McCarthy MK, Morrison TE. Deep mutationally scanned CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies. J Virol. 2025 Apr 15; 99(4):e0008125.
-
Rudy MJ, Wilson CJ, Hinckley B, Baker DC, Royal JM, Hoke MP, Brennan MB, Vogt MR, Clarke P, Tyler KL. EV68-228-N monoclonal antibody treatment halts progression of paralysis in a mouse model of EV-D68 induced acute flaccid myelitis. mBio. 2025 Apr 09; 16(4):e0390624.
-
Guthmiller JJ, Yu-Ling Lan L, Li L, Fu Y, Nelson SA, Henry C, Stamper CT, Utset HA, Freyn AW, Han J, Stovicek O, Wang J, Zheng NY, Huang M, Dugan HL, Tepora ME, Zhu X, Chen YQ, Palm AE, Shaw DG, Loganathan M, Francis BF, Sun J, Chervin J, Troxell C, Meade P, Leung NHL, Valkenburg SA, Cobey S, Cowling BJ, Wilson IA, Garc?a-Sastre A, Nachbagauer R, Ward AB, Coughlan L, Krammer F, Wilson PC. Long-lasting B cell convergence to distinct broadly reactive epitopes following vaccination with chimeric influenza virus hemagglutinins. Immunity. 2025 Apr 08; 58(4):980-996.e7.
-
Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup R?ge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC. Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019. J Infect Dis. 2025 Mar 17; 231(3):677-683.
-
Bokop C, Dhar N, Izu A, Ali MM, Akaba G, Barsosio HC, Berkley JA, Beck MM, Chaka TE, Cutland CL, Dorji P, Keita AM, Lema FB, Medugu N, Mwarumba S, Mwakio S, Obaro S, Olateju EK, Sahni RD, Saha SK, Santhanam S, Sharma R, Siga?que B, Simoes EAF, Sow SO, Tapia MD, Veeraraghavan B, Madhi SA, Kwatra G. Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: an observational, multicenter study. Int J Infect Dis. 2025 May; 154:107882.
-
Raja AI, Connor RI, Ashare A, Weiner JA, Wieland-Alter WF, Godin A, Modlin JF, Ackerman ME, Brickley EB, Wright PF. Binding and neutralising antibodies to respiratory syncytial virus and influenza A virus in serum and bronchoalveolar lavage fluid of healthy adults in the United States: A cross-sectional study. Vaccine. 2025 Apr 19; 53:126936.
-
Lin TH, Lee CD, Fern?ndez-Quintero ML, Ferguson JA, Han J, Zhu X, Yu W, Guthmiller JJ, Krammer F, Wilson PC, Ward AB, Wilson IA. Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genes. Nat Commun. 2025 Feb 02; 16(1):1268.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|